Correlation Between Reunion Neuroscience and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Reunion Neuroscience and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reunion Neuroscience and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reunion Neuroscience and ATyr Pharma, you can compare the effects of market volatilities on Reunion Neuroscience and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reunion Neuroscience with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reunion Neuroscience and ATyr Pharma.
Diversification Opportunities for Reunion Neuroscience and ATyr Pharma
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reunion and ATyr is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Reunion Neuroscience and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Reunion Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reunion Neuroscience are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Reunion Neuroscience i.e., Reunion Neuroscience and ATyr Pharma go up and down completely randomly.
Pair Corralation between Reunion Neuroscience and ATyr Pharma
If you would invest 112.00 in Reunion Neuroscience on October 2, 2024 and sell it today you would earn a total of 0.00 from holding Reunion Neuroscience or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.12% |
Values | Daily Returns |
Reunion Neuroscience vs. ATyr Pharma
Performance |
Timeline |
Reunion Neuroscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reunion Neuroscience and ATyr Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Reunion Neuroscience and ATyr Pharma
The main advantage of trading using opposite Reunion Neuroscience and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reunion Neuroscience position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.Reunion Neuroscience vs. Braxia Scientific Corp | Reunion Neuroscience vs. Oxford Nanopore Technologies | Reunion Neuroscience vs. Algernon Pharmaceuticals | Reunion Neuroscience vs. Awakn Life Sciences |
ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |